Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy.
Bandello F, Coassin M, Di Zazzo A, Rizzo S, Biagini I, Pozdeyeva N, Sinitsyn M, Verzin A, De Rosa P, Calabrò F, Avitabile T, Bonfiglio V, Fasce F, Barraquer R, Mateu JL, Kohnen T, Carnovali M, Malyugin B; Group LEADER-7 Investigators. Bandello F, et al. Among authors: pozdeyeva n. Eye (Lond). 2020 Nov;34(11):2112-2122. doi: 10.1038/s41433-020-0869-1. Epub 2020 May 4. Eye (Lond). 2020. PMID: 32366996 Free PMC article. Clinical Trial.
Correction: One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy.
Bandello F, Coassin M, Di Zazzo A, Rizzo S, Biagini I, Pozdeyeva N, Sinitsyn M, Verzin A, De Rosa P, Calabrò F, Avitabile T, Bonfiglio V, Fasce F, Barraquer R, Mateu JL, Kohnen T, Carnovali M, Malyugin B; Group LEADER-7 Investigators. Bandello F, et al. Among authors: pozdeyeva n. Eye (Lond). 2020 Nov;34(11):2150. doi: 10.1038/s41433-020-0987-9. Eye (Lond). 2020. PMID: 32467636 Free PMC article.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Morphometric analysis of the lens in human aniridia and mouse Small eye.
Voskresenskaya A, Pozdeyeva N, Batkov Y, Vasilyeva T, Marakhonov A, West RA, Caplan JL, Cvekl A, Wang Y, Duncan MK. Voskresenskaya A, et al. Among authors: pozdeyeva n. Exp Eye Res. 2021 Feb;203:108371. doi: 10.1016/j.exer.2020.108371. Epub 2020 Nov 26. Exp Eye Res. 2021. PMID: 33248069 Free PMC article.
[Effects of artificial gravity on perimetry results].
Malyugin BE, Koloteva MI, Pozdeyeva NA, Morozova TA, Sychova DV, Pikusova SM, Mashkov DA. Malyugin BE, et al. Among authors: pozdeyeva na. Vestn Oftalmol. 2021;137(2):26-33. doi: 10.17116/oftalma202113702126. Vestn Oftalmol. 2021. PMID: 33881260 Russian.
Keratoconus Diagnostic and Treatment Algorithms Based on Machine-Learning Methods.
Malyugin B, Sakhnov S, Izmailova S, Boiko E, Pozdeyeva N, Axenova L, Axenov K, Titov A, Terentyeva A, Zakaraiia T, Myasnikova V. Malyugin B, et al. Among authors: pozdeyeva n. Diagnostics (Basel). 2021 Oct 19;11(10):1933. doi: 10.3390/diagnostics11101933. Diagnostics (Basel). 2021. PMID: 34679631 Free PMC article.
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
21 results